Bilateral Retinoblastoma
Oncology·MeSH: Retinoblastoma
Prevalence
0.1 / 100K
6 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Melphalan | ENANTA PHARMACEUTICALS INC (ENTA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Bilateral Retinoblastoma?
BioSniper tracks 6 drugs in development for Bilateral Retinoblastoma across 1 company.
How many clinical trials target Bilateral Retinoblastoma?
There are 1 clinical trial targeting Bilateral Retinoblastoma tracked by BioSniper.
What is the prevalence of Bilateral Retinoblastoma?
The estimated prevalence of Bilateral Retinoblastoma is approximately 0.1 per 100,000 population.
Deep-dive into Bilateral Retinoblastoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis